360
N. Noguchi et al. / Tetrahedron: Asymmetry 24 (2013) 357–361
J = 9.0 Hz), 3.78 (6H, s), 2.03 (1H, dt, J = 15.4, 7.6 Hz), 1.86 (1H, dt,
J = 15.4, 7.6 Hz), 1.51 (3H, s), 1.26–1.19 (8H, m), 0.86 (3H, t,
J = 6.8 Hz); 13C NMR (100 MHz, CDCl3) d 176.2, 169.0, 156.2,
130.9, 121.6, 114.0, 55.4, 54.1, 52.7, 38.9, 31.5, 29.4, 25.1, 22.5,
21.1, 14.0; IR (neat) mmax 3336, 2932, 1714, 1666, 1602, 1516,
1246 cmꢁ1; HRMS (FAB) [M+H]+ Calcd for C18H28NO4: 322.2018.
Found: 322.2005; racemic mixture; ee was determined by HPLC;
DICEL CHIRALCEL OD-H 0.46 cm / ꢀ 25 cm; hexane/isopropa-
nol = 19/1; flow rate = 0.4 mL/min; retention time: 20.0, 22.0 min.
4.3.7. (S,E)-Methyl 3-phenylcarbamoylmethyl-5-phenylpenta-
noate 3f
The ee of 2f was determined by HPLC of 3f: Rf = 0.16 (hexane/
ethyl acetate = 4/1); 1H NMR (400 MHz, CDCl3) d 7.81 (1H, s),
7.52 (2H, d, J = 7.8 Hz), 7.33–7.17 (7H, m), 7.09 (1H, t, J = 7.6 Hz),
3.71 (3H, s), 2.71 (2H, t, J = 7.3 Hz), 2.56–2.38 (5H, m), 1.84–1.64
(2H, m); 13C NMR (100 MHz, CDCl3) d 173.5, 169.9, 141.5, 137.9,
128.9, 128.4, 128.3, 125.9, 124.1, 119.6, 51.8, 41.9, 37.7, 36.2,
33.3, 33.1; IR (KBr) mmax 3312, 3023, 2944, 2856, 1730, 1659,
1598, 1523, 1441, 1207, 1153 cmꢁ1; HRMS (FAB) [M+H]+ Calcd
for C20H24NO3: 326.1756. Found: 326.1751; ½a D28
¼ þ4:0 (c 0.5,
ꢂ
4.3.5. Methyl 6-phenylcarbamoyl-3-cyclohexenecarboxylate 3d
The ee of 2d was determined by HPLC of 3d: Rf = 0.14 (hexane/
ethyl acetate = 4/1); 1H NMR (400 MHz, CDCl3) d 8.01 (1H, s), 7.50
(2H, d, J = 8.3 Hz), 7.29 (2H, dd, J = 8.3, 7.3 Hz), 7.08 (1H, t,
J = 7.3 Hz), 5.77 (2H, s), 3.72 (3H, s), 3.14–3.05 (2H, m), 2.76–2.27
(4H, m); 13C NMR (100 MHz, CDCl3) d 174.7, 170.9, 137.9, 128.8,
125.6, 124.8, 124.0, 119.8, 52.1, 41.6, 40.6, 26.9, 26.0; IR (neat) mmax
CHCl3); 30% ee; ee was determined by HPLC; DICEL CHIRALCEL
OD-H 0.46 cm / ꢀ 25 cm; hexane/isopropanol = 3/1; flow
rate = 0.3 mL/min; retention time: 26.2 min for 3f, 29.4 min for
ent-3f. The absolute configuration of the product was determined
to be the same as that of compound 3f {½a D21
¼ þ8:1 (c 4.7, CHCl3),
ꢂ
93% ee}, which was prepared by the hydrogenation of 3e (93% ee),
by comparison of their specific rotation.
3324, 3032, 2952, 1730, 1666, 1602, 1538, 1442, 1250, 1206 cmꢁ1
;
HRMS (FAB) [M+H]+ Calcd for C15H18NO3: 260.1287. Found:
260.1279; Ee was determined by the HPLC analysis and found to
be 0% ee: DICEL CHIRALPAK AS-H 0.46 cm / ꢀ 25 cm; hexane/iso-
propanol = 3/1; flow rate = 0.3 mL/min; retention time: 31.5,
36.6 min.
Acknowledgments
This work was financially supported in part by The Grant-in-Aid
for Scientific Research on Innovative Areas ‘Organic Synthesis
based on Reaction Integration. Development of New Methods and
Creation of New Substances’ (No. 2105).
4.3.6. (S,E)-Methyl 3-phenylcarbamoylmethyl-5-phenylpent-4-
enoate 3e
References
The ee of 2e was determined by HPLC of 3e: Rf = 0.22 (hexane/
ethyl acetate = 2/1); 1H NMR (400 MHz, CDCl3) d 7.68 (1H, s), 7.49
(2H, d, J = 7.8 Hz), 7.33–7.19 (7H, m), 7.08 (1H, t, J = 7.3 Hz), 6.50
(1H, d, J = 15.9 Hz), 6.18 (1H, dd, J = 15.9, 8.1 Hz), 3.67 (3H, s),
3.28 (1H, dtt, J = 8.1, 7.1, 6.8 Hz), 2.67–2.51 (4H, m); 13C NMR
(100 MHz, CDCl3) d 172.5, 169.2, 137.7, 136.7, 131.1, 130.5,
128.9, 128.4, 127.4, 126.2, 124.2, 119.8, 51.8, 42.3, 38.8, 36.7; IR
(KBr) mmax 3345, 1736, 1655, 1600, 1527, 1256 cmꢁ1; mp 98.1–
98.6 °C; HRMS (FAB) [M+H]+ Calcd for C20H22NO3: 324.1600.
1. For selected papers. See: (a) Blaser, H. Chem. Rev. 1992, 92, 935–952; (b)
France, S.; Guerin, D. J.; Miller, G. S.; Lectka, T. Chem. Rev. 2003, 103,
2985–3012; (c) Wurz, R. Chem. Rev. 2007, 107, 5570–5595; (d) Shibasaki,
M.; Kanai, M. Chem. Rev. 2008, 108, 2853–2873; (e) Turner, N. J. Chem.
Rev. 2011, 111, 4073–4087; (f) Hall, M.; Bommarius, A. S. Chem. Rev. 2011,
111, 4088–4110; (g) Moyano, A.; Rios, R. Chem. Rev. 2011, 111, 4703–
4832; (h) Wang, J.; Liu, X.; Feng, X. Chem. Rev. 2011, 111, 6947–6983; (i)
Yus, M.; Gonzáez-Gómez, J.; Foubelo, F. Chem. Rev. 2011, 111, 7774–7854;
(j) Zhuo, C.-X.; Zhang, W.; You, S.-L. Angew. Chem., Int. Ed. 2012, 51,
12662–12686.
2. Hudlichy, T. Chem. Rev. 2011, 111, 3995–3997.
Found: 324.1591; ½a D27
¼ ꢁ27:4 (c 0.3, CHCl3); 98% ee. Ee was
ꢂ
3. (a) Brenna, E.; Fuganti, C.; Gatti, F. G.; Serra, S. Chem. Rev. 2011, 111, 4036–
4072; (b) Theil, F. Chem. Rev. 1995, 95, 2203–2227; (c) Santaniello, E.;
Ferraboschi, P.; Grisenti, P.; Manzocchi, A. Chem. Rev. 1992, 92, 1071–1140;
(d) Bjökling, F.; Boutelje, J.; Gatenbeck, S.; Hult, K.; Norin, T.; Szmulik, P.
Tetrahedron 1985, 41, 1347–1352; (e) Bjökling, F.; Boutelje, J.; Gatenbeck, S.;
Hult, K.; Norin, T.; Szmulik, P. Bioorg. Chem. 1986, 14, 176–181; (f) Luyten,
M.; Müler, S.; Herzog, B.; Keese, R. Helv. Chim. Acta 1987, 70, 1250–1254;
(g) Jeso, B. D.; Belair, N.; Deleuze, H.; Rascle, M.-C.; Maillard, B. Tetrahedron
Lett. 1990, 31, 653–654; (h) Zhu, L.-M.; Tedford, M. C. Tetrahedron 1990, 46,
6587–6611; (i) Andrade, M. A. C.; Andrade, F. A. C.; Phillips, R. S. Bioorg.
Med. Chem. Lett. 1991, 1, 373–376; (j) Provencher, L.; Wynn, H.; Jones, J. B.
Tetrahedron: Asymmetry 1993, 4, 2025–2040; (k) Trost, B. M.; Li, Y. J. Am.
Chem. Soc. 1996, 118, 6625–6633; (l) Alexadre, F. R.; Legoupy, S.; Huet, F.
Tetrahedron 2000, 56, 3921–3926; (m) Kedrowski, B. L. J. Org. Chem. 2003,
68, 5403–5406.
determined by the HPLC analysis; DICEL CHIRALPAK AS-H
0.46 cm / ꢀ 25 cm; hexane/isopropanol = 3/1; flow rate = 0.4 mL/
min; retention time: 42.8 min for ent-3e, 47.2 min for 3e. The abso-
lute configuration of the product was determined to be the same as
that of compound 3e {½a D20
¼ ꢁ40:8 (c 1.3, CHCl3), 93% ee}, which
ꢂ
was prepared from 2e14 (93% ee), by the comparison of their spe-
cific rotation.
The absolute configuration of 2e was determined by compari-
son of the specific rotation of its derivative 4e with the reported
data.15 Compound 2e was converted into 4e as follows:
4. (a) Servi, S. Synthesis 1990, 1–25; (b) Cusk, R.; Glänzer, B. I. Chem. Rev. 1991, 91,
49–97; (c) Hoegberg, H.-E.; Berglund, P.; Edlund, H.; Faegerhag, J.;
Hedenstroem, E.; Lundh, M.; Nordin, O.; Servi, S.; Voerde, C. Catal. Today
1994, 22, 591–606; (d) Mochizuki, N.; Hiramatsu, S.; Sugai, T.; Ohta, H.; Morita,
H.; Itokawa, H. Biosci. Biotechnol. Biochem. 1995, 59, 2282–2291; (e) Bertau, M.;
Burli, M. Chimica 2000, 54, 503–507; (f) Fuhshuku, K.; Tomita, M.; Sugai, T.
Tetrahedron Lett. 2004, 45, 1763–1767; (g) Watanabe, H.; Iwamoto, M.; Nakada,
M. J. Org. Chem. 2005, 70, 4652–4658.
MeO2C
CO2H
MeO2C
CO2H
H
H
H2, Pd/C (cat.)
EtOH, rt
Ph
Ph
5. (a) Domínguez de Maria, P.; García-Burgos, C. A.; Bargeman, G.; vanGemert, R.
W. Synthesis 2007, 1439–1452; (b) Tamm, C. Pure Appl. Chem. 1992, 64, 1187–
1191; (c) Jones, J. B. Aldrichim. Acta 1993, 26, 105–112.
6. Ager, D. J.; Prakash, I. Synth. Commun. 1995, 25, 739–742.
7. Ohno, M.; Otsuka, M. Org. React. 1989, 37, 1–55.
8. Schneider reported that the hydrolysis rate of the half-ester of sebacic acid
(Me2OC(CH2)8CO2H) by PLE was comparable to that of the corresponding
diester. See: Lobell, M.; Schneider, M. P. J. Chem. Soc., Perkin Trans. 1 1993,
1713–1714.
9. (a) Asakawa, K.; Noguchi, N.; Nakada, M. Heterocycles 2008, 76, 183–190; (b)
Asakawa, K.; Noguchi, N.; Takashima, S.; Nakada, M. Tetrahedron: Asymmetry
2008, 19, 2304–2309.
2e (93% ee)
O
O
1) (COCl)2, DMF (cat.)
CH2Cl2, rt
H
2) NaBH4, MeOH, THF
–30 °C to rt
then, 5 M HCl, rt
58% (3 steps)
Ph
4e
[α]D17 = –29.1 (c 2.4, CHCl3)
lit.15 [α]D25 = +14.5 (c 0.48, CHCl3) 85% ee
10. Noguchi, N.; Nakada, M. Org. Lett. 2006, 8, 2039–2042.
11. Tsuna, K.; Noguchi, N.; Nakada, M. Angew. Chem., Int. Ed. 2011, 50, 9452–9455.
4e:
ent-